officialstreetpreachers Subscribe
Published: May 21, 2021

J&J vaccine producer drilled at House hearing on botched vaccine doses, lavish executive bonuses, stock sales

By The Editor

LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.

May 21, 2021 (Children’s Health Defense) – Johnson & Johnson (J&J) documented serious contamination risks at a troubled Emergent Biosolutions Baltimore plant in June 2020 — seven months before a contamination incident ruined 15 million doses of COVID vaccine and derailed the company’s vaccine production plans.

The House Select Committee on Coronavirus launched a probe into Emergent last month after the company acknowledged “serious deficiencies” in the company’s manufacturing that caused a mix-up of AstraZeneca and J&J doses.

memorandum released prior to Wednesday’s hearing raised questions about J&J’s lack of oversight of the Baltimore facility. The memo also cited large bonuses paid to top executives despite failures, and described other evidence recently obtained by the Select Subcommittee on the Coronavirus Crisis and the Committee on Oversight and Reform in their ongoing investigation into Emergent.

The memo revealed:

Emergent was paid millions despite destroying millions of vaccine doses. The company charged the federal government $26 million per month in reservation fees to maintain its “readiness” to manufacture vaccines pursuant to “current good manufacturing practices.” As a result of these contract terms, taxpayers paid Emergent more than $271 million. New documents from

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors


Share this Article

Download the Mobile App.
Exit mobile version